COVID-19 Susceptibility in Pregnancy: Immune/inflammatory Considerations, the Role of Placental ACE-2 and Research Considerations
Overview
Reproductive Medicine
Affiliations
SARS-CoV-2 is a new virus, to which herd immunity has not yet developed and both molecular and serological testing are not without flaws. The virus evokes a state of severe and widespread inflammation, and stimulates both innate and adaptive immune response. The angiotensin-converting enzyme 2 (ACE2), which acts as the SARS-CoV-2 receptor, is present in endothelial cells and has been noted within the human placenta. There are questions about whether pregnancy would increase the susceptibility of pregnant women to COVID-19 and disease severity within this population. In this report, we highlight physiological and immune/inflammatory considerations that may explain the susceptibility and disease pathology in response to SARS CoV-2 during pregnancy, explore testing considerations in asymptomatic individuals, discuss the potential role and of placental ACE2 receptor in the pathogenesis of COVID-19 in pregnancy and in pregnancy outcomes, and finally share our perspective with respect to an urgently needed change concerning involvement of pregnant women in research addressing COVID-19.
Zhang J, Wu J, Zhang H, Li J, Li H Int J Womens Health. 2024; 16:1625-1631.
PMID: 39372668 PMC: 11453137. DOI: 10.2147/IJWH.S480448.
Chronopoulos J, Pernet E, Tran K, McGovern T, Morozan A, Wang S Sci Adv. 2024; 10(39):eado7087.
PMID: 39331716 PMC: 11430450. DOI: 10.1126/sciadv.ado7087.
Mukherjee J, Burman S, Sarkar S, Chowdhury R, Talukder A, Bera G J Family Med Prim Care. 2024; 13(6):2404-2409.
PMID: 39027878 PMC: 11254028. DOI: 10.4103/jfmpc.jfmpc_1156_23.
Svirsky R, Rabbi M, Hamad R, Sharabi-Nov A, Kugler N, Galoyan N Sci Rep. 2024; 14(1):10813.
PMID: 38734805 PMC: 11088702. DOI: 10.1038/s41598-024-61504-6.
Kumari P, Kumar A, Sinha C, Kumar A, Sk A, Vamshi C Trends Anaesth Crit Care. 2024; 39:3-4.
PMID: 38620902 PMC: 8114145. DOI: 10.1016/j.tacc.2021.04.009.